require prescribers to access the prescription drug monitoring program database prior to issuing a prescription to certain controlled substances.

Senators White (prime), Bolin, and Monroe and Representatives Stevens (prime), Haugaard, and Tieszen at the request of the Interim Substance Abuse Prevention Study Committee